Additional file 2 of Impact of the SARS-CoV-2 nucleocapsid 203K/204R mutations on the inflammatory immune response in COVID-19 severity

  • Muhammad Shuaib (Creator)
  • Sabir Adroub (Creator)
  • Tobias Mourier (Creator)
  • Sara Mfarrej (Creator)
  • Huoming Zhang (Creator)
  • Luke Esau (Creator)
  • Afrah Alsomali (Creator)
  • Fadwa S Alofi (Creator)
  • Adeel Nazir Ahmad (Creator)
  • Abbas Shamsan (Creator)
  • Asim Khogeer (Creator)
  • Anwar M Hashem (Creator)
  • Naif A M Almontashiri (Creator)
  • Sharif Hala (Creator)
  • Arnab Pain (Creator)

Dataset

Description

Additional file 2: Table S1. Demorgraphic and clinical information of all samples. Table S2. All significant DE genes (KR-patients versus Healthy). Table S3. All significant DE genes (RG-patients versus Healthy). Table S4. All DE genes (KR-patients versus RG-patients ). Table S5. Transcriptome Pathways enrichment (biological processes). Table S6. Significant DE genes KR-VLP versus control. Table S7. Significant DE genes D614G-VLP versus control. Table S8. Significant DE genes D614G-KR-VLP versus control. Table S9. Significant DE genes WT-VLP versus control. Table S10. Pathways enrichment (biological processes). Table S11. All DE proteins in KR, D614G-KR, and D614G versus WT. Table S12. Proteome Pathways enrichment (biological processes).
Date made available2023
Publisherfigshare

Access Dataset

Cite this